Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A400BU | ISIN: KYG1180K1168 | Ticker-Symbol:
NASDAQ
17.01.25
20:43 Uhr
0,510 US-Dollar
+0,018
+3,55 %
Branche
Medien
Aktienmarkt
JAPAN
1-Jahres-Chart
BLOOMZ INC Chart 1 Jahr
5-Tage-Chart
BLOOMZ INC 5-Tage-Chart
ACCESS Newswire
411 Leser
Artikel bewerten:
(2)

BloomZ Inc. Announces Closing of $5.38 Million Initial Public Offering

Finanznachrichten News

TOKYO, JAPAN / ACCESSWIRE / July 25, 2024 / BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), today announced the closing of its initial public offering of 1,250,000 ordinary shares (the "Ordinary Shares") at a public offering price of $4.30 per share, for aggregate gross proceeds of approximately $5.38 million, prior to deducting underwriting discounts and other offering expenses. The Company's Ordinary Shares began trading on the Nasdaq Capital Market on July 24, 2024, under the symbol "BLMZ".

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 Ordinary Shares at the public offering price per share, less the underwriting discount, to cover over-allotments, if any.

Network 1 Financial Securities, Inc. ("Network 1"), a full-service broker/dealer, acted as the sole book-running manager for the offering. HeartCore Enterprises, Inc. and Spirit Advisors LLC served as financial advisors and IPO consultants for the Company. Hunter Taubman Fischer & Li LLC is acting as U.S. legal counsel to BloomZ and Loeb & Loeb LLP is acting as U.S. legal counsel to Network 1 for the offering.

The offering is being conducted pursuant to the Company's registration statement on Form F-1, as amended (File No. 333-275223), relating to the Ordinary Shares initially filed with the U.S. Securities and Exchange Commission (the "SEC") on October 31, 2023, and was declared effective on July 1, 2024. The offering was made only by means of a prospectus. A final prospectus relating to the offering has been filed with the SEC on July 23, 2024, and is available on the SEC's website at www.sec.gov. Copies of the final prospectus related to the Offering may be obtained from Network 1 Financial Securities, Inc., 2 Bridge Avenue, Suite 241, Red Bank, NJ 07701, by phone at 732-758-9001 or by email at BLMZIPO@netw1.com.

Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About BloomZ Inc.

BloomZ is a Cayman Islands holding company with an operating subsidiary, Kabushiki Kaisha BloomZ ("BloomZ Japan"), in Japan. BloomZ Japan is a Japanese audio producing and voice actor and VTuber managing company. BloomZ Japan has experienced staff who have worked on audio production for animations and video games for more than 10 years. BloomZ Japan also manages, cultivates and promotes voice actors and VTubers.

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected gross proceeds and the closing of the offering. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the SEC, including, but not limited to, the risks detailed in the Company's preliminary prospectus (Registration No. 333-275223), initially filed with the SEC on October 31, 2023. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

BloomZ Investor Contact

John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
Email: bloomz@gateway-grp.com

SOURCE: BloomZ



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.